MicroRNA expression changes in lymphoblastoid cell lines in response to lithium treatment

International Journal of Neuropsychopharmacology

Volumn 12, Issue 7, 2009, Pages 975-981

  Chen, Haiming ^a   Wang, Nulang ^a   Burmeister, Margit ^a   McInnis, Melvin G ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

Lithium; Post transcription regulation; Target gene

Indexed keywords

LITHIUM CHLORIDE; MESSENGER RNA; MICRORNA; MIRNA 152; MIRNA 155; MIRNA 221; MIRNA 34A; UNCLASSIFIED DRUG;

ARTICLE; BIPOLAR DISORDER; CELL CULTURE; CONTROLLED STUDY; CULTURE MEDIUM; DRUG EFFECT; DRUG MECHANISM; DRUG RESPONSE; HIPPOCAMPUS; HUMAN; HUMAN CELL; LYMPHOBLASTOID CELL LINE; LYMPHOCYTE; PRIORITY JOURNAL;

ANTIMANIC AGENTS; BIPOLAR DISORDER; CASE-CONTROL STUDIES; CELL LINE; GENE EXPRESSION REGULATION; HUMANS; LITHIUM CHLORIDE; LYMPHOCYTES; MICHIGAN; MICRORNAS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TIME FACTORS;

EID: 69749113137     PISSN: 14611457     EISSN: 14695111     Source Type: Journal    
DOI: 10.1017/S1461145709000029     Document Type: Article

References (31)

1. Ambros V (2004). The functions of animal microRNAs. Nature 431, 350-355.
2. Baldessarini RJ, TondoL, Davis P,PompiliM,Goodwin FK, Hennen J (2006). Decreased risk of suicides and attempts during long-term lithium treatment: a meta-analytic review. Bipolar Disorders 8, 625-639.
3. Baldessarini RJ, Tondo L, Hennen J (2003). Lithium treatment and suicide risk in major affective disorders: update and new findings. Journal of Clinical Psychiatry 64 (Suppl. 5), 44-52.
4. Bartel DP (2004). MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116, 281-297.
5. Beveridge NJ, Tooney PA, Carroll AP, Gardiner E, Bowden N, Scott RJ, Tran N, Dedova I, Cairns MJ (2008). Dysregulation of miRNA 181b in the temporal cortex in schizophrenia. Human Molecular Genetics 17, 1156-1168.
6. Burmistrova OA, Goltsov AY, Abramova LI, Kaleda VG, Orlova VA, Rogaev EI (2007). MicroRNA in schizophrenia: genetic and expression analysis of miR-130b (22q11). Biochemistry (Moscow) 72, 578-582.
7. Cade JFJ (1949). Lithium salts in the treatment of psychotic excitement. Medical Journal of Australia 2, 349-352.
8. Calin GA, Croce CM (2006). MicroRNA signatures in human cancers. Nature Reviews Cancer 6, 857-866.
9. Chekanova JA, Belostotsky DA (2006). MicroRNAs and messenger RNA turnover. Methods in Molecular Biology 342, 73-85.
10. Dunner DL (1998). Lithium carbonate: maintenance studies and consequences of withdrawal. Journal of Clinical Psychiatry 59 (Suppl. 6), 48-55.
11. Eulalio A, Huntzinger E, Izaurralde E (2008). Getting to the root of miRNA-mediated gene silencing. Cell 132, 9-14.
12. Fabbri M, Ivan M, Cimmino A, Negrini M, Calin GA (2007). Regulatory mechanisms of microRNAs involvement in cancer. Expert Opinion on Biological Therapy 7, 1009-1019.
13. Filipowicz W, Bhattacharyya SN, Sonenberg N (2008). Mechanisms of post-transcriptional regulation by microRNAs: are the answers in sight? Nature Reviews Genetics 9, 102-114.
14. Griffiths-Jones S, Saini HK, van Dongen S, Enright AJ (2008). miRBase: tools for microRNA genomics. Nucleic Acids Research 36, D154-D158.
15. Guzzetta F, Tondo L, Centorrino F, Baldessarini RJ (2007). Lithium treatment reduces suicide risk in recurrent major depressive disorder. Journal of Clinical Psychiatry 68, 380-383.
16. Hansen T, Olsen L, Lindow M, Jakobsen KD, Ullum H, Jonsson E, Andreassen OA, Djurovic S, Melle I, Agartz I, et al. (2007). Brain expressed microRNAs implicated in schizophrenia etiology. PLoS ONE 2, e873.
17. Holland PM, Abramson RD, Watson R, Gelfand DH (1991). Detection of specific polymerase chain reaction product by utilizing the 5k-3k exonuclease activity of Thermus aquaticus DNA polymerase. Proceedings of the National Academy of Sciences USA 88, 7276-7280.
18. Hosack DA, Dennis Jr. G, Sherman BT, Lane HC, Lempicki RA (2003). Identifying biological themes within lists of genes with EASE. Genome Biology 4, R70.
19. Iwamoto K, Kakiuchi C, Bundo M, Ikeda K, Kato T (2004). Molecular characterization of bipolar disorder by comparing gene expression profiles of postmortem brains of major mental disorders. Molecular Psychiatry 9, 406-416.
20. Kato M, Slack FJ (2008). microRNAs: small molecules with big roles - C. elegans to human cancer. Biology of the Cell 100, 71-81.
21. Kim J, Inoue K, Ishii J, Vanti WB, Voronov SV, Murchison E, Hannon G, Abeliovich A (2007). A MicroRNA feedback circuit in midbrain dopamine neurons. Science 317, 1220-1224.
22. Kim VN, Nam JW (2006). Genomics of microRNA. Trends in Genetics 22, 165-173.
23. Landgraf P, Rusu M, Sheridan R, Sewer A, Iovino A, Aravin A, Pfeffer S, Rice A, Kamphorst AO, Landthaler M, et al. (2007). A mammalian microRNA expression atlas based on small RNA library sequencing. Cell 129, 1401-1414.
24. Lee I, Ajay SS, Chen H, Maruyama A, Wang N, McInnis MG, Athey BD (2008). Discriminating single-base difference miRNA expressions using microarray Probe Design Guru (ProDeG). Nucleic Acids Research 36, e27.
25. Liang Y, Ridzon D, Wong L, Chen C (2007). Characterization of microRNA expression profiles in normal human tissues. BMC Genomics 8, 166.
26. McQuillin A, Rizig M, Gurling HM (2007). A microarray gene expression study of the molecular pharmacology of lithium carbonate on mouse brain mRNA to understand the neurobiology of mood stabilization and treatment of bipolar affective disorder. Pharmacogenetics and Genomics 17, 605-617.
27. Perkins DO, Jeffries CD, Jarskog LF, Thomson JM, Woods K, Newnam MA, Parker JS, Jin J, Hammond SM (2007). microRNA expression in the prefrontal cortex of individuals with schizophrenia and schizoaffective disorder. Genome Biology 8, R27.
28. Thomson JM, Newman M, Parker JS, Morin-Kensicki EM, Wright T, Hammond SM (2006). Extensive post-transcriptional regulation of microRNAs and its implications for cancer. Genes & Development 20, 2202-2207.
29. Wang G, van der Walt JM, Mayhew G, Li YJ, Zuchner S, Scott WK, Martin ER, Vance JM (2008). Variation in the miRNA-433 binding site of FGF20 confers risk for Parkinson disease by overexpression of alpha-synuclein. American Journal of Human Genetics 82, 283-289.
30. Zhou R, Yuan P, Wang Y, Elkahloun A, Damschroder-Williams P, Chen G,Manji H (2007). Selective microRNAs known to regulate cell survival and growth are common hippocampal targets for lithium and valproate. The 46th American College of Neuropsychopharmacology Meeting (Abstract no. 158).
31. Zhou R, Yuan P, Wang Y, Hunsberger JG, Elkahloun A, Wei Y, Damschroder-Williams P, Du J, Chen G, Manji H (2008). Evidence for selective microRNAs and their effectors as common long-term targets for the actions of mood stabilizers. Neuropsychopharmacology. Published online: 13 August 2008. doi:10.1038/npp.2008.131.